Australia secures new COVID-fighting drug

By Georgie Moore
Updated October 4 2021 - 11:35am, first published 11:30am
Trials suggest Merck's new antiviral drug reduces COVID hospitalisations and deaths by around half.

Australia has closed a deal for 300,000 courses of an antiviral pill showing promising signs of slashing COVID-19 deaths and hospitalisations.

Advertisement

Ad

Advertisement

Ad

Advertisement

Ad

Get the latest Tamworth news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.